These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 8856152)

  • 1. Kinins in the cardiovascular system.
    Schölkens BA
    Immunopharmacology; 1996 Jun; 33(1-3):209-16. PubMed ID: 8856152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kallikrein-kinin system as a regulator of cardiovascular and renal function.
    Rhaleb NE; Yang XP; Carretero OA
    Compr Physiol; 2011 Apr; 1(2):971-93. PubMed ID: 23737209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
    Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
    Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular properties of the kallikrein-kinin system.
    Sharma JN; Sharma J
    Curr Med Res Opin; 2002; 18(1):10-7. PubMed ID: 11999140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of kinins in the pathophysiology of myocardial ischemia. In vitro and in vivo studies.
    Linz W; Wiemer G; Schölkens BA
    Diabetes; 1996 Jan; 45 Suppl 1():S51-8. PubMed ID: 8529801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple interactions between the renin-angiotensin and the kallikrein-kinin systems: role of ACE inhibition and AT1 receptor blockade.
    Tschöpe C; Schultheiss HP; Walther T
    J Cardiovasc Pharmacol; 2002 Apr; 39(4):478-87. PubMed ID: 11904521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinin-related effects of angiotensin-converting enzyme inhibition.
    Bönner G
    Clin Physiol Biochem; 1990; 8 Suppl 1():6-15. PubMed ID: 2257722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular interactions of vasoactive systems in cardiovascular damage.
    Bader M
    J Cardiovasc Pharmacol; 2001 Nov; 38 Suppl 2():S7-9. PubMed ID: 11811382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible protective effects of kinins and converting enzyme inhibitors in cardiovascular tissues.
    Nolly H; Miatello R; Damiani MT; Abate CD
    Immunopharmacology; 1997 Jun; 36(2-3):185-91. PubMed ID: 9228545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE inhibition, endothelial function and coronary artery lesions. Role of kinins and nitric oxide.
    Mombouli JV
    Drugs; 1997; 54 Suppl 5():12-22. PubMed ID: 9429841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical insights into the beneficial and protective actions of the kallikrein-kinin system.
    Regoli D; Gobeil F
    Vascul Pharmacol; 2015 Jan; 64():1-10. PubMed ID: 25579779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic targets and prototype therapeutics in the kallikrein-kinin system: bradykinin receptor agonists or antagonists.
    Sharma JN; Al-Sherif GJ
    ScientificWorldJournal; 2006 Oct; 6():1247-61. PubMed ID: 17041716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitors.
    Linz W; Schölkens BA
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S83-90. PubMed ID: 1282635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinins and endothelial control of vascular smooth muscle.
    Mombouli JV; Vanhoutte PM
    Annu Rev Pharmacol Toxicol; 1995; 35():679-705. PubMed ID: 7598512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kallikrein-kinin system as the dominant mechanism to counteract hyperactive renin-angiotensin system.
    Regoli D; Gobeil F
    Can J Physiol Pharmacol; 2017 Oct; 95(10):1117-1124. PubMed ID: 28384411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the kinin system mediate in cardiovascular abnormalities? An overview.
    Sharma JN
    J Clin Pharmacol; 2003 Nov; 43(11):1187-95. PubMed ID: 14551172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive and cardioprotective effects after angiotensin-converting enzyme inhibition: role of kinins.
    Tschöpe C; Gohlke P; Zhu YZ; Linz W; Schölkens B; Unger T
    J Card Fail; 1997 Jun; 3(2):133-48. PubMed ID: 9220313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The plasma and tissue kininogen-kallikrein-kinin system: role in the cardiovascular system.
    Marcondes S; Antunes E
    Curr Med Chem Cardiovasc Hematol Agents; 2005 Jan; 3(1):33-44. PubMed ID: 15638742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardioactive hormones: bradykinin].
    Dendorfer A; Simon M; Dominiak P
    Z Kardiol; 1996; 85 Suppl 6():211-8. PubMed ID: 9064968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
    Vora JP; Oyama TT; Thompson MM; Anderson S
    Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.